Lundbeck Wins Appellate Ruling On Cipralex Patent

Law360, New York (April 11, 2008, 12:00 AM EDT) -- A British appellate court has overturned a ruling that found claims in H. Lundbeck A/S’ patent for its antidepressant drug Cipralex insufficient, scoring a win for the Danish pharmaceutical company in an ongoing patent challenge brought by three generics makers.

In a sweeping victory for Lundbeck, a three-judge panel in the Supreme Court of Judicature, Court of Appeal in England and Wales overturned part of the lower court’s ruling that deemed Lundbeck’s patent insufficient and affirmed the rest of the ruling on Thursday, acknowledging the validity...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.